Navigation Links
Anadys Pharmaceuticals to Present at the Lazard Healthcare Conference
Date:11/10/2010

ard-looking statements."  Such statements include, but are not limited to, references to Anadys' strategy, development programs, and ability to develop novel medicines for the treatment of hepatitis C.  Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause Anadys' actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements.  For example, the results of preclinical and early clinical studies may not be predictive of future results, and Anadys cannot provide any assurances that ANA598 or ANA773 will not have unforeseen safety issues, will have favorable results in ongoing or future clinical trials or will receive regulatory approval.  Risk factors that may cause actual results to differ are more fully discussed in Anadys' SEC filings, including Anadys' Form 10-Q for the quarter ended September 30, 2010.  All forward-looking statements are qualified in their entirety by this cautionary statement.  Anadys is providing this information as of this date and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise.


'/>"/>
SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Anadys Pharmaceuticals to Report Fourth Quarter and Year End 2009 Financial Results
2. Anadys Pharmaceuticals Receives FDA Clearance of Phase II Protocol to Study ANA598 in Combination With Interferon-Alpha and Ribavirin in HCV Patients
3. Anadys Pharmaceuticals Reports Second Quarter 2009 Financial Results and Program Highlights
4. Anadys Pharmaceuticals to Report Second Quarter 2009 Financial Results
5. Anadys Pharmaceuticals, Inc. Announces Strategic Restructuring to Focus Operations on Continuing the Advancement of ANA598
6. Anadys Pharmaceuticals Reports First Quarter 2009 Financial Results and Highlights
7. Anadys Pharmaceuticals to Report First Quarter 2009 Financial Results
8. Anadys Pharmaceuticals to Present at Future Leaders in the Biotech Industry
9. Anadys Pharmaceuticals to Present at the Piper Jaffray Health Care Conference
10. Anadys Pharmaceuticals to Present at the Needham Focus on Infectious Disease Conference
11. Anadys Pharmaceuticals to Present at Rodman & Renshaw Annual Global Investment Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Scottsdale, Arizona (PRWEB) January 15, 2014 ... growth for Scottsdale’s Brain State Technologies®. They saw continued ... University Medical Center who were awarded a $1 million ... papers published in “Brain and Behavior” a peer reviewed ...
(Date:1/15/2014)... Jan. 15, 2014 TaiGen Biotechnology Company, Limited ("TaiGen") ... with R-Pharm, a leading Russian pharmaceutical company, to develop ... Russian Federation , Turkey ... (CIS). Nemonoxacin is a novel antibiotic for the treatment of ...
(Date:1/14/2014)... Histogen, Inc., a regenerative medicine company ... under simulated embryonic conditions, today announced that they have ... Inc. for physician-dispensed aesthetic products containing Histogen’s proprietary multipotent ... is an amendment to the existing license between Histogen ...
(Date:1/14/2014)... EquitiesIQ, a leading informational research provider, ... is an emerging biomedical company acquiring, developing, manufacturing, and ... , Free report download: http://equitiesiq.com/reports/alliqua/ , In ... team and Board, which launched the company’s new strategy ...
Breaking Biology Technology:Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3
... July 15 Amylin Pharmaceuticals,Inc. (Nasdaq: AMLN ) ... quarter of 2008 on Monday, July 21, 2008 at ... and Chief Executive,Officer, will lead the call. On the ... second quarter of 2008., The call will be ...
... Help Organizations ... Achieve Benefits of H.R. 6331, GREAT RIVER, ... enterprise-wide software and services for health and,human services organizations, today ... organizations understand electronic,prescribing and the new Medicare bill passed by ...
... Discussion on Benefits of Group Purchasing Organizations Hosted,by ... The American Society of,Healthcare Engineering (ASHE) offers ... years, annual conference is no exception. Added,to the ... leading global supplier of,indoor comfort systems and comprehensive ...
Cached Biology Technology:Amylin Pharmaceuticals to Webcast Second Quarter Results 2Netsmart Technologies Web Seminar Helps Behavioral Health Organizations Understand Electronic Prescribing and the Importance of New Medicare-Related E-Prescribing Legislation 2Netsmart Technologies Web Seminar Helps Behavioral Health Organizations Understand Electronic Prescribing and the Importance of New Medicare-Related E-Prescribing Legislation 3Healthcare Facility Managers Learn to Optimize Surgical Suites at 2008 ASHE Annual Conference 2Healthcare Facility Managers Learn to Optimize Surgical Suites at 2008 ASHE Annual Conference 3
(Date:7/10/2014)... organization funding cutting-edge, innovative research on Alzheimer,s disease ... degeneration, today announced the recipients of new research ... U.S. states, the District of Columbia, and five ... With these latest grants, BrightFocus has now provided ... 2014. , The research projects funded this year ...
(Date:7/10/2014)... Consuming a whole fresh avocado with either an ... A carotenoid (alpha- and beta-carotene) absorption and conversion of ... according to new research (1) published in ... Vitamin A is involved in reproductive health and growth ... and has antioxidant properties. Provitamin A carotenoids, like alpha- ...
(Date:7/9/2014)... Inflammatory diseases can occur simultaneously in distinct sites ... medication effective for one disorder may exacerbate the ... dexamethasone, which alleviates joint disease but can worsen ... issue of The American Journal of Pathology ... of anti-arthritic drugs, specifically DTrp8-ɣMSH (DTrp), that acts ...
Breaking Biology News(10 mins):BrightFocus Foundation announces 55 new grantees in Alzheimer's and vision research 2BrightFocus Foundation announces 55 new grantees in Alzheimer's and vision research 3New research: Fresh avocado enhances absorption of essential nutrients for healthy living 2New class of anti-arthritis drugs effectively treats multiple inflammatory diseases 2
... Introduce and Promote Technologies to APEC Delegates, SAN ... Board: TTNUF), a leading Biometric and security solutions,provider announced ... 7th,APEC (Asia-Pacific Economic Cooperation) Ministerial Meeting on,Telecommunication and Information ... 25. TELMIN 7 is being held in the aim ...
... A broad collaboration of research institutions in the U.S. and ... This draft, which spells out more than 90 percent of ... evolution of flowering plants. And because it involves a genetically ... detailed picture yet of the genetic changes that make the ...
... Brown University biologists shows that fruit flies live longer ... cells that create eggs and sperm. The work ... reproductive tissue directly control lifespan and metabolism in the ... of the National Academy of Sciences, also offers a ...
Cached Biology News:Titanium Group to Attend Regional ICT Meeting in Thailand 2Titanium Group to Attend Regional ICT Meeting in Thailand 3First draft of transgenic papaya genome yields many fruits 2First draft of transgenic papaya genome yields many fruits 3Eliminating germline lengthens fly lifespan, Brown study shows 2
... All MagCellect Ferrofluid products perform ... with R&D Systems MagCellect Magnet. ... this neodymium iron boron permanent ... x 75 mm test tubes ...
... 2'-O-Methyltransferase converts Cap 0 (or Cap 0-like) ... 1 structure has been shown to increase ... 50%. This improvement is seen in Cap ... Capping System as well as those Cap ...
Request Info...
Form: Ready to use Applications: Western Blot, ELISA...
Biology Products: